We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

Market capitalization of the largest public biotech companies jumps nearly 12% year-over-year, as all but five of them show ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of federal price negotiations, which are scheduled to begin this year, with ...

This month, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US.

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...